Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
arylalkylamine N-acetyltransferase
(
AA-NAT
) gene is strongly expressed in the rat primarily in the pineal gland; low levels of expression are also found in the retina.
AA-NAT
catalyzes the key regulatory step controlling rhythmic melatonin output: the acetylation of serotonin. In the rat, the
AA-NAT
gene is expressed at night. This is controlled partly by cyclic AMP (cAMP) acting through a composite cAMP-responsive element-CCAAT site located upstream of the transcription start point. In the present study, we have extended our previous in vitro findings and found that additional elements in the 5' flanking region and first intron play an important role in the regulation of the
AA-NAT
gene. This led us to test the influence of an
AA-NAT
5' flanking segment on the expression of the bacterial
chloramphenicol acetyltransferase
gene in a rat transgenic model. The results of this study clearly demonstrate that the segment of the
AA-NAT
gene that encompasses the minimal promoter and the first intron is able to confer the highly specific pineal/retinal and time-of-day patterns of
AA-NAT
gene expression. This advance also provides a tool that selectively targets genetic expression to pinealocytes and retinal photoreceptors, providing new experimental opportunities to probe gene expression in these tissues.
...
PMID:Genetic targeting: the serotonin N-acetyltransferase promoter imparts circadian expression selectively in the pineal gland and retina of transgenic rats. 1050 Nov 77
The bacterial gene
chloramphenicol acetyltransferase
(
CAT
) is a widely used reporter in both in-vitro and in-vivo studies of genetic regulation. We have recently generated novel rat transgenic lines carrying an
arylalkylamine N-acetyltransferase
(
AA-NAT
) promoter-reporter construct in which
CAT
(with associated SV40 small-t antigen sequence) is the reporter. In addition to the predicted transgene transcript (1.9 kb), we identified an abundant 1.5 kb transcript which derives from an alternative splicing event that utilises a cryptic splice donor site located within the
CAT
gene. The native
CAT
open reading frame (ORF) is lost in the 1.5 kb transcript, and a western analysis has shown that protein deriving from an aberrant open reading frame is not expressed at detectable levels.
...
PMID:Use of a cryptic splice donor site in the chloramphenicol acetyltransferase (CAT)-SV40 small-t antigen cassette generates alternative transcripts in transgenic rats. 1085 70